National Hospital Organization Kurihama Medical and Addiction Center, Kanagawa, Japan.
Alcohol Clin Exp Res. 2013 Aug;37(8):1391-401. doi: 10.1111/acer.12108. Epub 2013 Mar 29.
The presence of the less-active form of alcohol dehydrogenase-1B encoded by ADH1B*1/*1 (vs. 2 allele) and active form of aldehyde dehydrogenase-2 (ALDH2) encoded by ALDH21/*1 (vs. *2 allele) increases the risk of alcoholism in East Asians.
The subjects in this cross-sectional survey were 1,902 Japanese alcoholic men (≥40 years) who underwent ADH1B/ALDH2 genotyping.
Age-adjusted daily alcohol consumption did not differ according to the ADH1B/ALDH2 genotypes. The age-adjusted odds ratios (AORs; 95% confidence interval) for liver cirrhosis (LC; n = 359, 1.58 [1.19 to 2.09]), chronic calcific pancreatitis (CP; n = 80, 2.24 [1.20 to 4.20]), and diabetes mellitus (DM; n = 383, 1.51 [1.15 to 1.99]) were higher in the ADH1B2 allele carriers than in the ADH1B1/1 carriers. The AORs for LC (1.43 [1.01 to 2.02]), CP (1.68 [0.80 to 3.53]), DM (1.63 [1.15 to 2.30]), and hypertension (HT; n = 495, 1.52 [1.11 to 2.07]) were higher in the ALDH21/1 carriers than in the ALDH21/2 carriers. The ADH1B2-associated AOR for LC was 2.08 (1.46 to 2.94) among those aged 40 to 59 years, but 0.89 (0.56 to 1.43) among those aged 60 years or over, and the interaction between ADH1B genotype and age on the LC risk was significant (p = 0.009). When the group with non-LC and no/mild fibrosis was used as controls, the ADH1B2-associated AORs increased according to the severity of their liver disease: 1.67 (1.32 to 2.11) for the group with non-LC and serum type IV collagen values ≥200 ng/ml, 1.81 (1.24 to 2.63) for the group of Child-Pugh class A LC, and 3.17 (1.98 to 5.07) for the group with Child-Pugh class B/C LC. Anti-hepatitis C virus (HCV) antibody was positive in 103 patients, and the groups with a high anti-HCV antibody titer and either the ADH1B2/2 genotype or the ALDH21/1 genotype had the highest AORs (8.83 and 4.90, respectively). The population attributable fraction (PAF) due to the ADH1B2 allele was 29% for LC, 47% for CP, and 27% for DM, and the PAF due to the ALDH2*1/*1 genotype was 26% for LC, 34% for DM, and 30% for HT.
The ADH1B2 allele increased the AORs for LC, CP, and DM of the alcoholics, and the ALDH21/*1 genotype increased their AORs for LC, DM, and HT. HCV infection and genetic susceptibility had a synergistic effect on the AOR for LC.
东亚人群中,编码低活性型醇脱氢酶-1B(ADH1B1/1 对2 等位基因)的 ADH1B1/1(对2 等位基因)和编码高活性型乙醛脱氢酶-2(ALDH2)的 ALDH2*1/1(对2 等位基因)的存在增加了酗酒者患酒精中毒的风险。
本横断面调查的对象是 1902 名日本酒精中毒男性(≥40 岁),他们进行了 ADH1B/ALDH2 基因分型。
根据 ADH1B/ALDH2 基因型,年龄调整后的每日酒精摄入量没有差异。肝硬化(LC;n=359,1.58[1.19 至 2.09])、慢性钙化性胰腺炎(CP;n=80,2.24[1.20 至 4.20])和糖尿病(DM;n=383,1.51[1.15 至 1.99])的年龄调整比值比(AOR;95%置信区间)在 ADH1B2 等位基因携带者中较高。LC(1.43[1.01 至 2.02])、CP(1.68[0.80 至 3.53])、DM(1.63[1.15 至 2.30])和高血压(HT;n=495,1.52[1.11 至 2.07])的 AOR 在 ALDH21/1 携带者中较高。ADH1B2 与 LC 相关的 AOR 在 40 至 59 岁年龄组中为 2.08(1.46 至 2.94),但在 60 岁及以上年龄组中为 0.89(0.56 至 1.43),ADH1B 基因型和年龄对 LC 风险的交互作用具有统计学意义(p=0.009)。当使用非 LC 且无/轻度纤维化的组作为对照时,ADH1B2 相关的 AOR 随着肝脏疾病的严重程度而增加:非 LC 且血清 IV 型胶原值≥200ng/ml 的组为 1.67(1.32 至 2.11),Child-Pugh 分级 A LC 的组为 1.81(1.24 至 2.63),Child-Pugh 分级 B/C LC 的组为 3.17(1.98 至 5.07)。103 例患者抗丙型肝炎病毒(HCV)抗体阳性,高抗 HCV 抗体滴度且 ADH1B2/2 基因型或 ALDH21/1 基因型的组具有最高的 AOR(分别为 8.83 和 4.90)。ADH1B2 等位基因的人群归因分数(PAF)为 LC 29%、CP 47%和 DM 27%,ALDH2*1/*1 基因型的 PAF 为 LC 26%、DM 34%和 HT 30%。
ADH1B2 等位基因增加了酗酒者 LC、CP 和 DM 的 AOR,ALDH21/*1 基因型增加了他们 LC、DM 和 HT 的 AOR。HCV 感染和遗传易感性对 LC 的 AOR 有协同作用。